Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease

• Status: Withdrawn
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an open-label cross-over randomized control study comparing the effect of modafinil and methylphenidate in patients with Parkinson's disease with excessive daytime sleepiness.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: US Department of Veterans Affairs; VA Office of Research and Development
• Treatments: Armodafinil; Methylphenidate; Modafinil

Criteria

Inclusion Criteria:

• Veteran at study site

Exclusion Criteria:

• Patients unable to give consent

• Diagnosis of EDS prior to diagnosis of PD

• Brain injury due to trauma, CVA, tumor or anoxia